Shah Veer A, Martin Coleman O, Hawkins Angela M, Holloway William E, Junna Shilpa, Akhtar Naveed
Marion Bloch Neuroscience Institute, St. Luke's Plaza, Kansas City, Missouri, USA.
University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.
J Neurointerv Surg. 2016 Jun;8(6):568-70. doi: 10.1136/neurintsurg-2015-011763. Epub 2015 May 22.
The increasing utilization of balloon guide catheters (BGCs) in thrombectomy therapy for ischemic stroke has led to concerns about large-bore sheaths causing vascular groin complications.Objective To retrospectively assess the impact of large large-bore sheaths and vascular closure devices on groin complication rates at a comprehensive stroke center over a 10-year period.
Radiological and clinical records of patients with acute ischemic stroke who underwent mechanical endovascular therapy with an 8Fr or larger sheaths were reviewed. A groin complication was defined as the formation of a groin hematoma, retroperitoneal hematoma, femoral artery pseudoaneurysm, or the need for surgical repair. Information collected included size of sheath, type of hemostatic device, and anticoagulation status of the patient. Blood bank records were also analyzed to identify patients who may have had an undocumented blood transfusion for a groin hematoma.
A total of 472 patients with acute ischemic stroke who underwent mechanical thrombectomy with a sheath and BGC sized 8Fr or larger were identified. 260 patients (55.1%) had tissue Plasminogen Activator (tPA) administered as part of stroke treatment. Vascular closure devices were used in 97.9% of cases (n=462). Two patients were identified who had definite groin complications and a further two were included as having possible complications. There was a very low rate of clinically significant groin complications (0.4-0.8%) associated with the use of large-bore sheaths.
These findings suggest that concerns for groin complications should not preclude the use of BGCs and large-bore sheaths in mechanical thrombectomy for acute ischemic stroke.
在缺血性中风的血栓切除术治疗中,球囊导引导管(BGC)的使用日益增加,这引发了人们对大口径鞘管导致血管腹股沟并发症的担忧。目的:回顾性评估大口径鞘管和血管闭合装置对一家综合卒中中心10年间腹股沟并发症发生率的影响。
回顾了接受8Fr或更大鞘管机械血管内治疗的急性缺血性中风患者的放射学和临床记录。腹股沟并发症定义为腹股沟血肿、腹膜后血肿、股动脉假性动脉瘤的形成或手术修复的必要性。收集的信息包括鞘管尺寸、止血装置类型和患者的抗凝状态。还分析了血库记录,以确定可能因腹股沟血肿接受过未记录输血的患者。
共确定472例接受鞘管和BGC尺寸为8Fr或更大的机械血栓切除术的急性缺血性中风患者。260例患者(55.1%)接受了组织型纤溶酶原激活剂(tPA)作为中风治疗的一部分。97.9%的病例(n=462)使用了血管闭合装置。确定有2例患者出现明确的腹股沟并发症,另有2例被列为可能出现并发症。使用大口径鞘管相关的临床显著腹股沟并发症发生率非常低(0.4-0.8%)。
这些发现表明,对腹股沟并发症的担忧不应妨碍在急性缺血性中风的机械血栓切除术中使用BGC和大口径鞘管。